Navigation Links
Osteoporosis Drugs: right time to take-off

Millions of Indians are at risk of developing osteoporosis. While women are more likely to develop the disease, men are equal sufferers from it. It is estimated that at the age of 50, a woman has a 40 per cent chance of developing an osteoporotic fracture during her remaining lifetime. Drugs, which are used to treat osteoporosis, can be grouped into two classes. The first category comprises agents, which limit the rate of bone loss and are referred to as ‘‘anti-resorption drugs’’. The second group of drugs promotes bone formation and is referred to as ‘‘bone forming drugs’’.

// No single class of drugs is perceived to manage osteoporosis on a standalone basis. Hormone Replacement Therapy (HRT) and bisphosphonates are the most prescribed drugs. Calcium, vitamins and alfacalcidol preparations are also prescribed for prevention. The anti-osteoporosis market includes multinationals like Glaxo-Smithkline, Novartis, Infar and Wyeth Lederle. The Indian companies who have notched up a substantial market share are Cipla, Dr Reddy’s Laboratories and Elder Pharmaceuticals.

The Indian osteoporosis medications market presents great opportunity. Indian pharmaceutical companies need to increase awareness levels about the disease and it’s implications on both the physician as well as patient level. New compounds that rebuild bone mass and are associated with minimal side effects represent another area of opportunity. Currently, Selective Oestrogen Receptors Modulators (SERMs) such as Raloxifene and new generation bisphosphonates such as Risedronate have not been introduced in the Indian market. These drugs have a better efficacy and fewer side effects than the current therapies.

The osteoporosis medications market is viewed as a typical lifestyle related disease with high brand loyalty. Current lifestyle disease markets like cardiovascular and diabetes therapies are gradually getting saturated. The time is right for Indian pharmaceutical companies to focus on the osteoporosis medications market. br>

'"/>




Related medicine news :

1. New treatment for Osteoporosis
2. Osteoporosis in men
3. Fluoride Found Effective in Osteoporosis
4. Mutation connected to Osteoporosis
5. Osteoporosis associated with Childhood Cancer
6. A treatment for Osteoporosis
7. Osteoporosis could be caused by irregular periods
8. Back exercises reduces Osteoporosis
9. Osteoporosis and kidney stones gene marker identified
10. The Answer To Prevent Osteoporosis
11. Blood Tests Can Help Detect Osteoporosis Early In Life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... ... 2017 , ... Apple Rehab Shelton Lakes , which specializes in the ... facility as part of a disaster drill on October 3rd. , Apple Rehab participated ... Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid Plan ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017  AllianceRx Walgreens Prime, the combined ... Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), ... which included the unveiling of new signage at its ... well as at a few other company-owned facilities across ... to patients, some of whom will begin to see ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: